- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0085400

Medicure Formulations Private Limited
About Medicure Formulations Private Limited
Data last updated:
Medicure Formulations Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 03 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC335486. Its GSTIN is 27AANCM2145E1ZJ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jayprakash Yadav and Pooja Jayprakash Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 8 Shanti Garden Chs Shrushti Opposite Surya Shopping Centre Mira Road, Thane, Maharashtra, India – 401107.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.69 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹9.6 Lakh (net margin 3.6%) and EBITDA of ₹15.92 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Medicure Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0085400).
Recognitions & Rankings of Medicure Formulations
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No 8 Shanti Garden Chs Shrushti Opposite Surya Shopping Centre Mira Road, Thane, Maharashtra, India – 401107
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medicure Formulations Private Limited
The main business activity of Medicure Formulations is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medicure Formulations Private Limited FY 2025 filings available
Medicure Formulations Private Limited reported revenue of ₹2.69 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medicure Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 46% over three years, including 22% growth in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medicure Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.92 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.6 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medicure Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medicure Formulations are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Medicure Formulations Private Limited
Medicure Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayprakash Yadav | Director | 03 Jan 2020 | 6 Years 9 Months | Current |
| Pooja Jayprakash Yadav | Director | 03 Jan 2020 | 6 Years 9 Months | Current |
Peer Comparison of Medicure Formulations Private Limited
Medicure Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chilika Pharmaceutical Private Limited | ₹2.69 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | Deoghar, Jharkhand, India |
| Andromeda Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Indore, Madhya Pradesh, India |
| Aten Porus Lifesciences Private Limited | ₹2.69 Cr (FY 2024) | •••• | •••• | -72.0% | •••• | Bangalore, Karnataka, India |
| Siddharth Medicare Private Limited | ₹2.69 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Patna, Bihar, India |
| Futurelife Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2019) | •••• | •••• | 50.0% | •••• | Vadodara, Gujarat, India |
| Medicure Formulations Private Limited this company | ₹2.69 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Thane, Maharashtra, India |
| Zaria Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Thane, Maharashtra, India |
| Conset Pharma Private Limited | ₹2.69 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Indore, Madhya Pradesh, India |
| Morya Hospital Private Limited | ₹2.68 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Satara, Maharashtra, India |
| Rynel Clifton Pharma Private Limited | ₹2.68 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | Hisar, Haryana, India |
| Med-Esales Life Sciences Private Limited | ₹2.68 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Medicure Formulations by revenue in the Pharma industry (Formulations, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Medicure Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medicure Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2024 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Medicure Formulations Private Limited
Employment history and EPFO contributions of people linked to Medicure Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medicure Formulations Private Limited
Medicure Formulations Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Jayprakash Yadav was appointed as Director on 03 Jan 2020.
Credit Ratings, Litigation & Regulatory Alerts for Medicure Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medicure Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medicure Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medicure Formulations Private Limited
Medicure Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AANCM2145E1ZJ | Maharashtra | Active | 19 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medicure Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicure Formulations Private Limited
Medicure Formulations is an active private limited company based in Thane, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 03 January 2020 (6+ years old) and is registered under CIN U51909MH2020PTC335486.
Medicure Formulations reported revenue of ₹2.69 Cr for FY 2025 (up 22% YoY).
Medicure Formulations has 2 current directors:
- Jayprakash Yadav - Director
- Pooja Jayprakash Yadav - Director
Medicure Formulations reported a net profit of ₹9.6 Lakh (net margin 3.6%) and EBITDA of ₹15.92 Lakh (EBITDA margin 5.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medicure Formulations is 46% over three years. In the latest year (FY 2025) revenue rose 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medicure Formulations is 27AANCM2145E1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medicure Formulations is U51909MH2020PTC335486. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicure Formulations was incorporated on 03 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medicure Formulations by revenue are Chilika Pharmaceutical Private Limited, Andromeda Pharmaceuticals Private Limited, Aten Porus Lifesciences Private Limited, Siddharth Medicare Private Limited, Futurelife Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharma Retail and Distribution).
Jayprakash Yadav was appointed as Director on 03 Jan 2020. Pooja Jayprakash Yadav was appointed as Director on 03 Jan 2020.
Yes, Medicure Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0085400).